Dr. Qingfeng Zheng 郑庆丰
Chief Physician, Associate Professor
Department of Thoracic Surgical Oncology, Fujian Cancer Hospital, Fuzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and minimally invasive laparoscopic treatment of esophageal, lung, esophagogastric junction, mediastinal, and chest wall tumors.
Dr. Zheng holds a medical doctorate and serves as an associate professor and master’s supervisor at Fujian Medical University and Fujian University of Traditional Chinese Medicine. In 2008, Dr. Zheng trained in thoracoscopic and mediastinoscopic surgery at Peking University People’s Hospital. In 2013, Dr. Zheng visited Queen Mary Hospital (University of Hong Kong) and Prince of Wales Hospital (Chinese University of Hong Kong) to study minimally invasive thoracic surgery, endoscopic diagnosis, and robotic surgery.
Professional roles
- Member, Esophageal Cancer Professional Committee, China Anti-Cancer Association
- Member, Youth Committee, Lung Cancer Professional Committee, China Anti-Cancer Association
- Member, Youth Committee, Thoracic Surgery Professional Committee, Chinese Research Hospital Association
- Standing Committee Member, Esophageal Cancer Expert Committee, Tumor Rehabilitation Branch, Chinese Society of Gerontology and Geriatrics
Name order: in Chinese the family name comes first (Zheng Qingfeng). Papers usually list the name as Qingfeng Zheng or Zheng Q.
Selected publications
10 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Immunol, 2026 (senior author): Engineered CAR-T extracellular vesicles loaded with miR-17-5p inhibitor suppress hepatocellular carcinoma progression. PubMed 42819479
- Sci Rep, 2026 (senior author): A Rho GTPase-related gene signature predicts prognosis and reveals an immunosuppressive microenvironment in lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencing data. PubMed 42469385
- Int Immunopharmacol, 2024 (senior author): Exosomal transfer of HCC-derived miR-17-5p downregulates NK cell function by targeting RUNX1-NKG2D axis. PubMed 38820961
- Biosci Rep, 2021 (senior author): Association between microRNA-146a, -499a and -196a-2 SNPs and non-small cell lung cancer: a case-control study involving 2249 subjects. PubMed 33554246
- Pathol Res Pract, 2020 (senior author): CircRNA_102179 promotes the proliferation, migration and invasion in non-small cell lung cancer cells by regulating miR-330-5p/HMGB3 axis. PubMed 32911346
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion